TELES Informationstechnologien AG (TLIK) - Net Assets
Based on the latest financial reports, TELES Informationstechnologien AG (TLIK) has net assets worth €0.00 EUR (≈ $0.00 USD) as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€4.29 Million ≈ $5.01 Million USD) and total liabilities (€4.29 Million ≈ $5.01 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check TLIK asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €0.00 |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | -100.0% |
| 10-Year Change | N/A |
| Growth Volatility | 3682.58 |
TELES Informationstechnologien AG - Net Assets Trend (2003–2024)
This chart illustrates how TELES Informationstechnologien AG's net assets have evolved over time, based on quarterly financial data. Also explore TELES Informationstechnologien AG (TLIK) total assets for the complete picture of this company's asset base.
Annual Net Assets for TELES Informationstechnologien AG (2003–2024)
The table below shows the annual net assets of TELES Informationstechnologien AG from 2003 to 2024. For live valuation and market cap data, see TELES Informationstechnologien AG market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €0.00 ≈ $0.00 |
-- |
| 2023-12-31 | €-5.10 Million ≈ $-5.97 Million |
-1445.89% |
| 2022-12-31 | €379.23K ≈ $443.36K |
-76.44% |
| 2021-12-31 | €1.61 Million ≈ $1.88 Million |
+12000.32% |
| 2020-12-31 | €13.30K ≈ $15.55K |
-- |
| 2019-12-31 | €0.00 ≈ $0.00 |
-- |
| 2018-12-31 | €-9.46 Million ≈ $-11.06 Million |
+1.69% |
| 2017-12-31 | €-9.62 Million ≈ $-11.25 Million |
+5.21% |
| 2016-12-31 | €-10.15 Million ≈ $-11.86 Million |
+23.07% |
| 2015-12-31 | €-13.19 Million ≈ $-15.42 Million |
-12.31% |
| 2014-12-31 | €-11.75 Million ≈ $-13.73 Million |
-13.73% |
| 2013-12-31 | €-10.33 Million ≈ $-12.07 Million |
+3.03% |
| 2012-12-31 | €-10.65 Million ≈ $-12.45 Million |
-37.84% |
| 2011-12-31 | €-7.73 Million ≈ $-9.03 Million |
-7.17% |
| 2010-12-31 | €-7.21 Million ≈ $-8.43 Million |
-250.68% |
| 2009-12-31 | €4.79 Million ≈ $5.59 Million |
-60.20% |
| 2008-12-31 | €12.02 Million ≈ $14.06 Million |
-82.89% |
| 2007-12-31 | €70.29 Million ≈ $82.17 Million |
-45.14% |
| 2006-12-31 | €128.12 Million ≈ $149.78 Million |
-4.36% |
| 2005-12-31 | €133.96 Million ≈ $156.61 Million |
+352.06% |
| 2004-12-31 | €29.63 Million ≈ $34.64 Million |
-46.61% |
| 2003-12-31 | €55.51 Million ≈ $64.89 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to TELES Informationstechnologien AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 403.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €6.23 Million | % |
| Other Components | €3.16 Million | % |
| Total Equity | €0.00 | 100.00% |
TELES Informationstechnologien AG Competitors by Market Cap
The table below lists competitors of TELES Informationstechnologien AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cyanotech Corporation
NASDAQ:CYAN
|
$2.22 Million |
|
Rakovina Therapeutics Inc
V:RKV
|
$2.22 Million |
|
Winchester Energy Ltd
AU:WEL
|
$2.22 Million |
|
KEY Petroleum Ltd
AU:KEY
|
$2.22 Million |
|
Mantex AB
ST:MANTEX
|
$2.21 Million |
|
Baronsmead Second Venture Trust Plc
LSE:BMD
|
$2.21 Million |
|
Bounty Oil & Gas NL
AU:BUY
|
$2.21 Million |
|
Uscom Ltd
AU:UCM
|
$2.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in TELES Informationstechnologien AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -5,104,000 to 0, a change of 5,104,000.
- Net loss of 835,237 reduced equity.
- Other comprehensive income decreased equity by 13,085,999.
- Other factors increased equity by 19,025,236.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-835.24K | -0.0% |
| Other Comprehensive Income | €-13.09 Million | -0.0% |
| Other Changes | €19.03 Million | +0.0% |
| Total Change | €- | % |
Book Value vs Market Value Analysis
This analysis compares TELES Informationstechnologien AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | €19.85 | €0.30 | x |
| 2004-12-31 | €11.15 | €0.30 | x |
| 2005-12-31 | €50.66 | €0.30 | x |
| 2006-12-31 | €48.51 | €0.30 | x |
| 2007-12-31 | €26.53 | €0.30 | x |
| 2008-12-31 | €4.55 | €0.30 | x |
| 2009-12-31 | €1.69 | €0.30 | x |
| 2010-12-31 | €-2.48 | €0.30 | x |
| 2011-12-31 | €-2.65 | €0.30 | x |
| 2012-12-31 | €-3.66 | €0.30 | x |
| 2013-12-31 | €-3.55 | €0.30 | x |
| 2014-12-31 | €-4.03 | €0.30 | x |
| 2015-12-31 | €-4.53 | €0.30 | x |
| 2016-12-31 | €-3.48 | €0.30 | x |
| 2017-12-31 | €-3.30 | €0.30 | x |
| 2018-12-31 | €-3.25 | €0.30 | x |
| 2019-12-31 | €-1.60 | €0.30 | x |
| 2020-12-31 | €0.00 | €0.30 | x |
| 2021-12-31 | €0.26 | €0.30 | x |
| 2022-12-31 | €0.06 | €0.30 | x |
| 2023-12-31 | €-0.82 | €0.30 | x |
| 2024-12-31 | €0.00 | €0.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently TELES Informationstechnologien AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -127.02%
- • Asset Turnover: 0.16x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (258.67%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 20.17% | 14.70% | 0.88x | 1.56x | €5.65 Million |
| 2004 | 8.43% | 3.14% | 0.89x | 3.03x | €-466.30K |
| 2005 | 82.45% | 435.23% | 0.16x | 1.20x | €97.05 Million |
| 2007 | 3.59% | 13.12% | 0.23x | 1.20x | €-4.50 Million |
| 2008 | -287.24% | -145.22% | 0.97x | 2.03x | €-35.74 Million |
| 2009 | -163.77% | -38.77% | 0.93x | 4.52x | €-8.29 Million |
| 2010 | 0.00% | -92.13% | 1.25x | 0.00x | €-14.04 Million |
| 2011 | 0.00% | -31.74% | 1.26x | 0.00x | €-3.05 Million |
| 2012 | 0.00% | -23.71% | 1.68x | 0.00x | €-1.87 Million |
| 2013 | 0.00% | 13.58% | 2.40x | 0.00x | €2.49 Million |
| 2014 | 0.00% | -15.51% | 3.70x | 0.00x | €-600.40K |
| 2015 | 0.00% | -22.39% | 4.96x | 0.00x | €-113.80K |
| 2016 | 0.00% | 48.12% | 5.41x | 0.00x | €4.15 Million |
| 2017 | 0.00% | 7.38% | 3.60x | 0.00x | €1.48 Million |
| 2018 | 0.00% | -57.68% | 3.63x | 0.00x | €-2.09 Million |
| 2019 | 0.00% | 93.03% | 1.50x | 0.00x | €4.34 Million |
| 2020 | 6198.86% | 29.26% | 2.40x | 88.46x | €823.18K |
| 2021 | 16.62% | 10.61% | 0.88x | 1.77x | €106.55K |
| 2022 | -446.97% | -78.41% | 1.21x | 4.69x | €-1.73 Million |
| 2023 | 0.00% | -4.86% | 5.02x | 0.00x | €-2.37 Million |
| 2024 | 0.00% | -127.02% | 0.16x | 0.00x | €-835.24K |
Industry Comparison
This section compares TELES Informationstechnologien AG's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $17,594,957,286
- Average return on equity (ROE) among peers: -11.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| TELES Informationstechnologien AG (TLIK) | €0.00 | 20.17% | N/A | $2.22 Million |
| AKSO HEALTH GR. (SPADR)/3 (8HX) | $12.29 Million | -137.16% | 4.11x | $1.60 Billion |
| EDAP TMS S.A (EDA) | $26.25 Million | -7.45% | 1.10x | $105.70 Million |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) | $19.26 Billion | 10.70% | 0.47x | $457.61 Million |
| Medios AG (ILM1) | $510.19 Million | 2.46% | 0.83x | $311.23 Million |
| M1 Kliniken AG (M12) | $29.75 Million | 22.29% | 0.12x | $300.08 Million |
| Paragon Care Limited (PXS) | $121.52 Million | 6.81% | 1.40x | $152.88 Million |
| Sigma Healthcare Limited (S5YA) | $477.77 Million | 0.38% | 1.46x | $18.92 Billion |
| Sinopharm Group Co. Ltd (X2S) | $120.32 Billion | 7.52% | 2.19x | $3.15 Billion |
About TELES Informationstechnologien AG
Arzneiwerk AG VIDA engages in the supply of pharmaceuticals for newly developed or rare medicines in Europe. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.